Carregant...
The Evolving Role of Tumor Treating Fields in Managing Glioblastoma: Guide for Oncologists
Glioblastoma (GBM) is a devastating brain tumor with poor prognosis despite advances in surgery, radiation, and chemotherapy. Survival of patients with glioblastoma remains poor, with only 1 in 4 patients alive at 2 years, and a 5-year survival rate of about 5%. Recurrence is nearly universal and, a...
Guardat en:
| Publicat a: | Am J Clin Oncol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Lippincott Williams & Wilkins
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5779316/ https://ncbi.nlm.nih.gov/pubmed/28832384 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COC.0000000000000395 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|